Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules

Journal of Infectious Diseases

Volumn 175, Issue 2 SUPPL., 1997, Pages

  Modlin, John F ^a   Halsey, Neal A ^c   Thoms, Mary Lou ^c   Meschievitz, Carlton K ^c   Patriarca, Peter A ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOIDY; DOSE RESPONSE; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; POLIOMYELITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS EXCRETION;

EID: 16944367385     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.supplement_1.s228     Document Type: Article

References (7)

1. Hull HF, Ward NA, Hull BP, Milstien JB, de Quadros C. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994; 343: 1331-7.
2. Strebel PM, Sutler RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 1992; 14:568-79.
3. Bernier RH. Improved inactivated poliovirus vaccine: an update. Pediatr Infect Dis J 1986; 5:289-92.
4. McBean AM, Modlin JF. Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine use in the United States. Pediatr Infect Dis J 1987; 6:881-7.
5. Institute of Medicine, National Academy of Sciences. An evaluation of poliomyelitis vaccine policy options. Washington, DC: National Academy of Sciences, 1988.
6. Robertson SE, Traverso HP, Drucker JA, et al. Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine. Lancet 1988; 1:897-9.
7. Meinert C. Clinical trials. New York: Oxford Press, 1986.